Vivos Therapeutics, Inc.
Vivos Therapeutics, Inc. (VVOS) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
vvos · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Vivos Therapeutics, Inc. (VVOS) measures how much investors pay for each dollar of the company's trailing earnings. VVOS's current PE ratio of N/A is calculated by dividing its stock price of $0.88 by its TTM earnings per share of -$1.72.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2018 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Devices · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Vivos Therapeutics, Inc.You VVOS | $5M | N/A | — | -$1.72 |
 Adagio Medical Holdings, Inc. ADGM | $11M | N/A | — | -$1.51 |
 Aethlon Medical, Inc. AEMD | $2M | N/A | — | -$85.77 |
 Allurion Technologies Inc. ALUR | $6M | N/A | — | -$0.38 |
 American Shared Hospital Services AMS | $9M | N/A | — | -$0.23 |
 Adlai Nortye Ltd. ANL | $543M | N/A | — | -$3.33 |
 Envoy Medical, Inc. COCH | $14M | N/A | — | -$1.21 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-2.07 | — | |
2024-12-31 FY2024 | — | $-2.22 | — | |
2023-12-31 FY2023 | — | $-11.14 | — | |
2022-12-31 FY2022 | — | $-25.90 | — | |
2021-12-31 FY2021 | — | $-23.89 | — | |
2020-12-31 FY2020 | — | $-16.55 | — | |
2019-12-31 FY2019 | — | $-21.66 | — | |
2018-12-31 FY2018 | — | $-18.27 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Vivos Therapeutics, Inc. (VVOS) measures how much investors pay for each dollar of the company's trailing earnings. VVOS's current PE ratio of N/A is calculated by dividing its stock price of $0.88 by its TTM earnings per share of -$1.72.
Frequently asked questions
VVOS pe ratio · 6 questionsVVOS's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.88 and TTM EPS of -$1.72. Data sourced from Financial Modeling Prep via VVOS's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Vivos Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09